All lobbying filings
SALT POINT STRATEGIES
Lobbying for VERTEX PHARMACEUTICALS · Biopharmaceutical company.
Filing
Registration
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Feb 24, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
Massachusetts
Lobbyists on this filing
1
-
ADAM BUCKALEW New on this filingPreviously held: Covered Official Positions Continued: Deputy Chief of Staff, U.S. Rep. Markwayne Mullin (R-OK); Communications Director & Legislative Assistant, U.S. Rep. Gregg Harper (R-MS)
Lobbying activity
1
Non-opioid pain relief and drug pipeline issues.